Task Group 36
Radiation Dose to Patients in Diagnostic Nuclear Medicine

A Task Group under Committee 2 and Committee 3

The objective of the TG is to develop dose coefficients for radiopharmaceuticals administered to patients in diagnostic nuclear medicine.

The main work of the TG is to update Publication 128 (2015) by values calculated using new ICRP adult and paediatric reference voxel phantoms, Publication 107 nuclear decay data and Publication 103 dosimetry methodology as well as to develop biokinetic models for new substances and to identify substances contained in Publication 128 where model improvements are needed. As far as reasonable, a harmonisation of dosimetric and biokinetic models with those developed by TG 95 (IDC) for the ICRP OIR and EIR documents is intended.

For the calculation of dose coefficients for patients, a computer code IDAC 2.0 is being developed. The new dosimetric and biokinetic models will be implemented into this code, and a quality assurance procedure with the BfS code DOSAGE which is also used for QA in the IDC TG will be organised.

Augusto Giussani (Chair), Federal Office for Radiation Protection (BfS), Germany
Sren Mattsson (Honourary Co-Chair), Skne University Hospital Malm and Lund University, Sweden
Martin Andersson (Secretary), Gothenburg University , Sweden
Wesley E. Bolch (Member), University of Florida, USA
Makoto Hosono (Member), Kindai University, Japan
Alexandra Kamp (Member), Federal Office for Radiation Protection (BfS), Germany
Keon Kang (Member), Seoul National University, Korea
Sigrid Leide-Svegborn (Member), Skane University Hospital Malm, Sweden
Dietmar Nosske (Member), Germany
Juan Camilo Ocampo Ramos (Member), Memorial Sloan Kettering Cancer Center, USA
Nina Petoussi-Henss (Member), Helmholtz Zentrum Mnchen, Germany
Katrine Riklund (Member), Ume, SWEDEN
Marie Sydoff (Member), Skane University Hospital, Lund, Sweden
Lars Sderberg (Member), Skåne University Hospital, Sweden